Correction: Identification and validation of neutrophils-related subtypes and prognosis model in triple negative breast cancer
Saved in:
Main Authors: | Shanqi Li, Yuzhou Qian, Wanchen Xie, Xinyu Li, Jiaying Wei, Long Wang, Guosheng Ren, Xuedong Yin |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2024-12-01
|
Series: | Journal of Cancer Research and Clinical Oncology |
Online Access: | https://doi.org/10.1007/s00432-024-06048-y |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinicopathological characteristics and long-term prognosis of triple-negative breast cancer patients with HER2-Low expression: a retrospective propensity score-matched cohort study
by: Xin Liu, et al.
Published: (2024-12-01) -
Comparative survival outcomes of neoadjuvant and adjuvant therapy in patients with T1c, node-negative, triple-negative breast cancer: A population-based analysis
by: Yi-Zi Zheng, et al.
Published: (2025-02-01) -
Impact of Paracoccus sp. EGY7 carotenoids on triple-negative breast cancer cells: invitro study
by: Karim Abdelazim, et al.
Published: (2025-02-01) -
The value of inflammation-related indicators in chemotherapy efficacy and disease-free survival of triple-negative breast cancer
by: Jie Zhu, et al.
Published: (2025-02-01) -
Neoadjuvant apatinib addition to sintilimab and carboplatin-taxane based chemotherapy in patients with early triple-negative breast cancer: the phase 2 NeoSAC trial
by: Guoshuang Shen, et al.
Published: (2025-02-01)